Australia - inglés - Department of Health (Therapeutic Goods Administration)

haleon australia pty ltd - fluticasone propionate, quantity: 50 microgram/actuation - spray, nasal - excipient ingredients: benzalkonium chloride; hydrochloric acid; glucose; purified water; polysorbate 80; dispersible cellulose; phenethyl alcohol - for the prophylaxis or treatment of allergic rhinitis for up to 6 months in adults 18 years and over.

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

elpen pharmaceutical co. inc. - salmeterol; fluticasone propionate - inhalation powder, pre-dispensed - 50/250 microgram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Australia - inglés - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - salmeterol xinafoate, quantity: 0.0725 mg (equivalent: salmeterol, qty 0.05 mg); fluticasone propionate, quantity: 0.5 mg - inhalation, powder for - excipient ingredients: lactose monohydrate - for the regular treatment of asthma, where the use of a combination product is appropriate. this may include: ?patients on effective maintenance doses of long-acting beta-2 agonists and inhaled corticosteroids ?patients who are symptomatic on current inhaled corticosteroid therapy,for the symptomatic treatment of patients with severe copd (fev1 <50% predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular beta-2 agonist bronchodilator therapy. fluticasone salmeterol ciphaler 500/50 is not indicated for the initiation of bronchodilator therapy in copd.

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - salmeterol xinafoate; fluticasone propionate - pressurised inhalation, suspension - 25/250 microgram(s)/dose - salmeterol and fluticasone

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - salmeterol xinafoate; fluticasone propionate - pressurised inhalation, suspension - 25/250 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - salmeterol xinafoate; fluticasone propionate - inhalation powder, pre-dispensed - 50 mcg/250 microgram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

rowex ltd - salmeterol; fluticasone propionate - inhalation powder, pre-dispensed - 50 microg/250 microgram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

ltt pharma limited - salmeterol xinafoate; fluticasone propionate - powder for inhalation - 50/250 microgram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

rowex ltd - salmeterol xinafoate; fluticasone propionate - pressurised inhalation, suspension - 25 microgram/250 microgram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

lexon (uk) ltd - salmeterol; fluticasone propionate - powder for inhalation - 50/250 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salmeterol and fluticasone